carbachol has been researched along with Atresia, Esophageal in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Capeto, FA | 1 |
| Lima, FJ | 1 |
| Okoba, W | 1 |
| Ramos, FL | 1 |
| Messias, TF | 1 |
| Rigonatto, GA | 1 |
| Sbragia, L | 1 |
| Magalhães, PJ | 1 |
| Melo-Filho, AA | 1 |
1 other study available for carbachol and Atresia, Esophageal
| Article | Year |
|---|---|
Contractile profile of esophageal and gastric fundus strips in experimental doxorubicin-induced esophageal atresia.
Topics: Animals; Antibiotics, Antineoplastic; Carbachol; Cholinergic Agonists; Disease Models, Animal; Doxor | 2015 |